New on F1000Research – 8 December 2014
8 December, 2014 | Eva Amsen |
|
|
A selection of new content on F1000Research from the past week. To receive notification of all new articles, sign up for our table of contents alerts.
Featured article
A common feature pharmacophore for FDA-approved drugs inhibiting the Ebola virus [v1; ref status: indexed, https://f1000r.es/4qh]
Sean Ekins, Joel S. Freundlich, Megan Coffee
“We propose that these drugs identified to date as inhibitors of the Ebola virus may be targeting VP35. These computational models may provide preliminary insights into the molecular features that are responsible for their activity against Ebola virus in vitro and in vivo and we propose that this hypothesis could be readily tested.”
Selected other articles that passed peer review this week
Connecting undergraduate science education with the needs of today’s graduates [v1; ref status: indexed, https://f1000r.es/4pl]
Viviane Callier, Richard H. Singiser, Nathan L. Vanderford
Cytoscape tools for the web age: D3.js and Cytoscape.js exporters [v2; ref status: indexed, https://f1000r.es/4k7]
Keiichiro Ono, Barry Demchak, Trey Ideker
APOC3 may not be a predictor of risk of ischemic vascular disease in the Chinese population [v1; ref status: indexed, https://f1000r.es/4oi]
Liang Tang, Zhi-Peng Cheng, Qing-Yun Wang, Wei Zeng, Hui Liu, Ying-Ying Wu, Bei Hu, Yu Hu
Active transmembrane drug transport in microgravity: a validation study using an ABC transporter model [v1; ref status: indexed, https://f1000r.es/41n]
Sergi Vaquer, Elisabet Cuyàs, Arnau Rabadán, Albert González, Felip Fenollosa, Rafael de la Torre
|